SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
95 hedge funds and large institutions have $170M invested in scPharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 35 increasing their positions, 21 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
40% more capital invested
Capital invested by funds: $121M → $170M (+$48.8M)
23% more funds holding
Funds holding: 77 → 95 (+18)
2.69% less ownership
Funds ownership: 77.16% → 74.46% (-2.7%)
Holders
95
Holding in Top 10
2
Calls
$721K
Puts
$154K
Top Buyers
| 1 | +$9.34M | |
| 2 | +$5.7M | |
| 3 | +$3.65M | |
| 4 |
AIC
AWM Investment Company
New York
|
+$3.49M |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$3.42M |
Top Sellers
| 1 | -$1.54M | |
| 2 | -$955K | |
| 3 | -$952K | |
| 4 |
Renaissance Technologies
New York
|
-$740K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$465K |